Active, Not Recruiting
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
NCT04229979
- Conditions
- Acute Myeloid Leukemia, Disease Attributes, Disease Progression, +10 more
- Locations
-
- O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
- UCLA Medical Hematology and Oncology Los Angeles, California, United States
- The Oncology Institute of Hope and Innovation Whittier, California, United States
- Colorado Blood Cancer Institute - SCRI - PPDS Denver, Colorado, United States